FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2002103223> ?p ?o ?g. }

• W2002103223 endingPage "343" @default.
• W2002103223 startingPage "336" @default.
• W2002103223 abstract "Fas stimulation recruits neutrophils and activates macrophages that secrete tumor necrosis factor-alpha (TNF-alpha), which aggravates Fas-mediated liver injury. To determine whether nonsteroidal anti-inflammatory drugs modify these processes, we challenged 24-hour-fasted mice with the agonistic Jo2 anti-Fas antibody (4 microg/mouse), and treated the animals 1 h later with saline or ibuprofen (250 mg/kg), a dual cyclooxygenase (COX)-1 and COX-2 inhibitor. Ibuprofen attenuated the Jo2-mediated recruitment/activation of myeloperoxidase-secreting neutrophils/macrophages in the liver, and attenuated the surge in serum TNF-alpha. Ibuprofen also minimized hepatic glutathione depletion, Bid truncation, caspase activation, outer mitochondrial membrane rupture, hepatocyte apoptosis and the increase in serum alanine aminotransferase (ALT) activity 5 h after Jo2 administration, to finally decrease mouse mortality at later times. The concomitant administration of pentoxifylline (decreasing TNF-alpha secretion) and infliximab (trapping TNF-alpha) likewise attenuated the Jo2-mediated increase in TNF-alpha, the decrease in hepatic glutathione, and the increase in serum ALT activity 5 h after Jo2 administration. The concomitant administration of the COX-1 inhibitor, SC-560 (10 mg/kg) and the COX-2 inhibitor, celecoxib (40 mg/kg) 1 h after Jo2 administration, also decreased liver injury 5 h after Jo2 administration. In contrast, SC-560 (10 mg/kg) or celecoxib (40 or 160 mg/kg) given alone had no significant protective effects. In conclusion, secondary TNF-alpha secretion plays an important role in Jo2-mediated glutathione depletion and liver injury. The combined inhibition of COX-1 and COX-2 by ibuprofen attenuates TNF-alpha secretion, glutathione depletion, mitochondrial alterations, hepatic apoptosis and mortality in Jo2-treated fasted mice." @default.
• W2002103223 created "2016-06-24" @default.
• W2002103223 creator A5001368886 @default.
• W2002103223 creator A5014762373 @default.
• W2002103223 creator A5020074171 @default.
• W2002103223 creator A5021514439 @default.
• W2002103223 creator A5033760050 @default.
• W2002103223 creator A5037075898 @default.
• W2002103223 creator A5038627604 @default.
• W2002103223 creator A5043643675 @default.
• W2002103223 creator A5063105170 @default.
• W2002103223 creator A5082052709 @default.
• W2002103223 date "2008-09-15" @default.
• W2002103223 modified "2023-10-14" @default.
• W2002103223 title "Ibuprofen administration attenuates serum TNF-α levels, hepatic glutathione depletion, hepatic apoptosis and mouse mortality after Fas stimulation" @default.
• W2002103223 cites W1497420961 @default.
• W2002103223 cites W1976194505 @default.
• W2002103223 cites W1977567003 @default.
• W2002103223 cites W1982161161 @default.
• W2002103223 cites W1985799274 @default.
• W2002103223 cites W1985844039 @default.
• W2002103223 cites W1999879498 @default.
• W2002103223 cites W2010207474 @default.
• W2002103223 cites W2011951102 @default.
• W2002103223 cites W2018251493 @default.
• W2002103223 cites W2020076608 @default.
• W2002103223 cites W2023325861 @default.
• W2002103223 cites W2023601511 @default.
• W2002103223 cites W2027113170 @default.
• W2002103223 cites W2033964378 @default.
• W2002103223 cites W2035247274 @default.
• W2002103223 cites W2043738387 @default.
• W2002103223 cites W2050939682 @default.
• W2002103223 cites W2059136414 @default.
• W2002103223 cites W2060388798 @default.
• W2002103223 cites W2075593832 @default.
• W2002103223 cites W2087852901 @default.
• W2002103223 cites W2100456820 @default.
• W2002103223 cites W2102688901 @default.
• W2002103223 cites W2111074132 @default.
• W2002103223 cites W2113802856 @default.
• W2002103223 cites W2136684700 @default.
• W2002103223 cites W2142631669 @default.
• W2002103223 cites W2154179429 @default.
• W2002103223 cites W2312622132 @default.
• W2002103223 cites W2410234746 @default.
• W2002103223 doi "https://doi.org/10.1016/j.taap.2008.05.010" @default.
• W2002103223 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/18572215" @default.
• W2002103223 hasPublicationYear "2008" @default.
• W2002103223 type Work @default.
• W2002103223 sameAs 2002103223 @default.
• W2002103223 citedByCount "21" @default.
• W2002103223 countsByYear W20021032232012 @default.
• W2002103223 countsByYear W20021032232013 @default.
• W2002103223 countsByYear W20021032232014 @default.
• W2002103223 countsByYear W20021032232015 @default.
• W2002103223 countsByYear W20021032232016 @default.
• W2002103223 countsByYear W20021032232017 @default.
• W2002103223 countsByYear W20021032232019 @default.
• W2002103223 countsByYear W20021032232021 @default.
• W2002103223 countsByYear W20021032232022 @default.
• W2002103223 crossrefType "journal-article" @default.
• W2002103223 hasAuthorship W2002103223A5001368886 @default.
• W2002103223 hasAuthorship W2002103223A5014762373 @default.
• W2002103223 hasAuthorship W2002103223A5020074171 @default.
• W2002103223 hasAuthorship W2002103223A5021514439 @default.
• W2002103223 hasAuthorship W2002103223A5033760050 @default.
• W2002103223 hasAuthorship W2002103223A5037075898 @default.
• W2002103223 hasAuthorship W2002103223A5038627604 @default.
• W2002103223 hasAuthorship W2002103223A5043643675 @default.
• W2002103223 hasAuthorship W2002103223A5063105170 @default.
• W2002103223 hasAuthorship W2002103223A5082052709 @default.
• W2002103223 hasConcept C126322002 @default.
• W2002103223 hasConcept C17991360 @default.
• W2002103223 hasConcept C181199279 @default.
• W2002103223 hasConcept C185592680 @default.
• W2002103223 hasConcept C190283241 @default.
• W2002103223 hasConcept C2779944601 @default.
• W2002103223 hasConcept C538909803 @default.
• W2002103223 hasConcept C55493867 @default.
• W2002103223 hasConcept C71924100 @default.
• W2002103223 hasConcept C98274493 @default.
• W2002103223 hasConceptScore W2002103223C126322002 @default.
• W2002103223 hasConceptScore W2002103223C17991360 @default.
• W2002103223 hasConceptScore W2002103223C181199279 @default.
• W2002103223 hasConceptScore W2002103223C185592680 @default.
• W2002103223 hasConceptScore W2002103223C190283241 @default.
• W2002103223 hasConceptScore W2002103223C2779944601 @default.
• W2002103223 hasConceptScore W2002103223C538909803 @default.
• W2002103223 hasConceptScore W2002103223C55493867 @default.
• W2002103223 hasConceptScore W2002103223C71924100 @default.
• W2002103223 hasConceptScore W2002103223C98274493 @default.
• W2002103223 hasIssue "3" @default.
• W2002103223 hasLocation W20021032231 @default.
• W2002103223 hasLocation W20021032232 @default.
• W2002103223 hasOpenAccess W2002103223 @default.
• W2002103223 hasPrimaryLocation W20021032231 @default.
• W2002103223 hasRelatedWork W2001431596 @default.

• next